Astonea Labs disclosed its related party transactions for the half year ended March 31, 2026, reporting a total transaction value of ₹3,204.06 lakh. The filing, submitted to BSE Limited, details transactions with key managerial personnel, directors, and associate concerns in compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure encompasses remuneration, sitting fees, reimbursements, and commercial transactions such as the sale and purchase of goods. Significant transactions include sales to associate concern Astonea One Private Limited, which accounted for a substantial portion of the activity. Loans extended to relatives of directors were also recorded during the period.

Transactions with Key Managerial Personnel and Directors

Remuneration and fees constituted a major component of the transactions with related parties. Managing Director Ashish Gulati received ₹60.33 lakh, while Chief Financial Officer Sumit Kumar and Company Secretary Ankit Kapoor received ₹5.00 lakh and ₹3.05 lakh respectively. Independent directors were paid sitting fees ranging from ₹0.18 lakh to ₹0.34 lakh.

Commercial Transactions with Associate Concerns

Transactions with associate concerns primarily involved the sale and purchase of goods and services. Astonea One Private Limited was the largest counterparty for sales of goods or services, with a transaction value of ₹2,627.74 lakh. Other associate concerns such as Shinto Organics, Ascot Biolabs Private Limited, and LV Life Sciences also engaged in significant trading activities.

Loans to Related Parties

The company extended loans to relatives of directors and an associate concern during the half year. Harsh Gulati and Usha Gulati, relatives of directors, had outstanding loan balances of ₹190.35 lakh and ₹160.35 lakh respectively. Ascot Biolabs Private Liited also received a loan, though the balance stood at nil by the end of the period.

astonea labs has re-appointed Mr. Rajan Talwar as its Tax Auditor for the financial year 2026-27. The Board of Directors approved the re-appointment on May 30, 2026, following the recommendation of the Audit Committee. This decision ensures continuity in the company's tax audit and compliance functions under the Income Tax Act, 1961.

The re-appointment is pursuant to Section 44AB of the Income Tax Act, 1961, and other applicable statutory provisions. Mr. Talwar, a partner at M/s. Avnish Sharma & Associates, Chartered Accountants, brings approximately three decades of experience in direct and indirect taxation, audit, and compliance management. He holds a Peer Review Certificate No. 016702.

Appointment Details

The Board approved the re-appointment for the Financial Year 2026-27. The terms of the appointment are mutually agreed upon between the company and the Tax Auditor. Mr. Talwar is not related to any Director or Key Managerial Personnel of the company.

The disclosure was made to BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.